• Your First Consultation is Free at All Our Centers!

Email : info@acimc.org
  Contact : +92-304-111-2229/BABY
WhatsApp : +92-309-333-2229/BABY

Select Language: English English اردو اردو

ERA (Endometrial Receptivity Analysis)


IVF

Overview

  • ERA is a diagnostic test patented in 2009 that helps to evaluate the woman’s endometrial receptivity.
  • ERA identifies a patient’s unique “window of implantation” (WOI) leading to a personalized embryo transfer (pET).
  • 3 in every 10 patients have a displaced WOI. In such cases, a second endometrial biopsy is needed to identify when the patient is receptive.

Benefits

  • ERA identifies the window of implantation (WOI) and recommends the best time for embryo transfer thereby increasing the chances of a successful outcome.
  • The ERA test has proven highly sensitive and accurate in detecting gene expression profiles associated with endometrial receptivity.
  • ERA improved pregnancy rates up to 85% following personalized embryo transfer made according to ERA test results.

Indications

  • Women who have experienced implantation failures with morphologically good quality embryos.
  • Women with a morphologically normal uterus and normal endometrial thickness (≥ 6 mm), where the uterus and endometrium are unlikely to be the problem.